New hope for kids with rare bleeding disorder
NCT ID NCT07455006
Summary
This study aims to see if a new drug called QL0911 is safe and effective at raising platelet counts in children with a chronic bleeding disorder called immune thrombocytopenia (ITP). It will involve 60 children aged 1 to 18 who have not responded well to previous treatments. The main goal is to see if the drug can keep platelet counts at a safe level for at least 6 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA, IMMUNE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.